TNF Pharmaceuticals, Inc.
USD5.20
+1.69 (+48.15%)
CEO
Mitchell Glass
IPO Date
2014-01-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.63
Prev. Close
$3.51
Day Low
$4.20
Day High
$8.90
52W Low
$3.24
52W High
$195.00
Market Cap
$0.01B
Volume
60.41M
| -0.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -31.3% | -22.4% | 0.00 | 1.17 | -0.0 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -103.4% | -86.6% | 0.01 | 1.95 | -0.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -126.4% | -120.5% | 0.01 | 12.18 | -0.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 180.5% | -1402.1% | -0.79 | 0.06 | -0.0 |
| -1.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -13.2% | -7.6% | 0.00 | 1.71 | -0.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -15.5% | -10.5% | 0.00 | 0.93 | -0.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -8.1% | -6.0% | 0.00 | 1.37 | -0.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -14.0% | -9.6% | 0.00 | 1.40 | -0.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -11.3% | -8.0% | 0.00 | 1.72 | -0.0 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -2502.2% | -36.3% | 0.07 | 2.48 | -0.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -95.7% | -67.6% | 0.00 | 0.62 | -0.0 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -18.5% | -13.2% | 0.00 | 1.17 | -0.0 |